CVE-2020-27264 - OpenCVE

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications use deterministic keys, which allows unauthenticated, physically proximate attackers to brute-force the keys via Bluetooth Low Energy.

No CVSS v4.0

Attack Vector Adjacent Network

Attack Complexity Low

Privileges Required None

Scope Unchanged

Confidentiality Impact High

Integrity Impact High

Availability Impact High

User Interaction None

No CVSS v3.0

Access Vector Adjacent Network

Access Complexity Low

Authentication None

Confidentiality Impact Partial

Integrity Impact None

Availability Impact None

AV:A/AC:L/Au:N/C:P/I:N/A:N

This CVE is not in the KEV list.

Key SSVC decision points have not yet been added.

Vendors	Products
Sooil	Anydana-a Anydana-a Firmware Anydana-i Anydana-i Firmware Diabecare Rs Diabecare Rs Firmware

Configuration 1 [-]

AND

cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*

cpe:2.3:h:sooil:anydana-a:-:*:*:*:*:*:*:*

Configuration 2 [-]

AND

cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*

cpe:2.3:h:sooil:anydana-i:-:*:*:*:*:*:*:*

Configuration 3 [-]

AND

cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*

cpe:2.3:h:sooil:diabecare_rs:-:*:*:*:*:*:*:*

No data.

References

Link	Providers
https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01

History

No history.

MITRE

Status: PUBLISHED

Assigner: icscert

Published: 2021-01-19T20:46:53

Updated: 2024-08-04T16:11:36.425Z

Reserved: 2020-10-19T00:00:00

Link: CVE-2020-27264

Vulnrichment

No data.

NVD

Status : Analyzed

Published: 2021-01-19T21:15:14.110

Modified: 2021-01-22T15:55:57.520

Link: CVE-2020-27264

Redhat

No data.

{"containers": {"cna": {"affected": [{"product": "SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A", "vendor": "n/a", "versions": [{"status": "affected", "version": "Dana Diabecare RS, AnyDana-i, AnyDana-A All versions prior to 3.0"}]}], "descriptions": [{"lang": "en", "value": "In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications use deterministic keys, which allows unauthenticated, physically proximate attackers to brute-force the keys via Bluetooth Low Energy."}], "problemTypes": [{"descriptions": [{"cweId": "CWE-330", "description": "USE OF INSUFFICIENTLY RANDOM VALUES CWE-330", "lang": "en", "type": "CWE"}]}], "providerMetadata": {"dateUpdated": "2021-01-19T20:46:53", "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6", "shortName": "icscert"}, "references": [{"tags": ["x_refsource_MISC"], "url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01"}], "x_legacyV4Record": {"CVE_data_meta": {"ASSIGNER": "ics-cert@hq.dhs.gov", "ID": "CVE-2020-27264", "STATE": "PUBLIC"}, "affects": {"vendor": {"vendor_data": [{"product": {"product_data": [{"product_name": "SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A", "version": {"version_data": [{"version_value": "Dana Diabecare RS, AnyDana-i, AnyDana-A All versions prior to 3.0"}]}}]}, "vendor_name": "n/a"}]}}, "data_format": "MITRE", "data_type": "CVE", "data_version": "4.0", "description": {"description_data": [{"lang": "eng", "value": "In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications use deterministic keys, which allows unauthenticated, physically proximate attackers to brute-force the keys via Bluetooth Low Energy."}]}, "problemtype": {"problemtype_data": [{"description": [{"lang": "eng", "value": "USE OF INSUFFICIENTLY RANDOM VALUES CWE-330"}]}]}, "references": {"reference_data": [{"name": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01", "refsource": "MISC", "url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01"}]}}}, "adp": [{"providerMetadata": {"orgId": "af854a3a-2127-422b-91ae-364da2661108", "shortName": "CVE", "dateUpdated": "2024-08-04T16:11:36.425Z"}, "title": "CVE Program Container", "references": [{"tags": ["x_refsource_MISC", "x_transferred"], "url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01"}]}]}, "cveMetadata": {"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6", "assignerShortName": "icscert", "cveId": "CVE-2020-27264", "datePublished": "2021-01-19T20:46:53", "dateReserved": "2020-10-19T00:00:00", "dateUpdated": "2024-08-04T16:11:36.425Z", "state": "PUBLISHED"}, "dataType": "CVE_RECORD", "dataVersion": "5.1"}

{"configurations": [{"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:o:sooil:anydana-a_firmware:*:*:*:*:*:*:*:*", "matchCriteriaId": "808DBA89-C2C2-4C03-814D-DB0B4DFF8B22", "versionEndExcluding": "3.0", "vulnerable": true}], "negate": false, "operator": "OR"}, {"cpeMatch": [{"criteria": "cpe:2.3:h:sooil:anydana-a:-:*:*:*:*:*:*:*", "matchCriteriaId": "2624582E-762F-4CDB-B974-1BC971F1544D", "vulnerable": false}], "negate": false, "operator": "OR"}], "operator": "AND"}, {"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:o:sooil:anydana-i_firmware:*:*:*:*:*:*:*:*", "matchCriteriaId": "98E25B7D-C1ED-4144-8411-171C7B6426E4", "versionEndExcluding": "3.0", "vulnerable": true}], "negate": false, "operator": "OR"}, {"cpeMatch": [{"criteria": "cpe:2.3:h:sooil:anydana-i:-:*:*:*:*:*:*:*", "matchCriteriaId": "E25CB863-07D9-4E90-8022-6C2B4C52EDFC", "vulnerable": false}], "negate": false, "operator": "OR"}], "operator": "AND"}, {"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:o:sooil:diabecare_rs_firmware:*:*:*:*:*:*:*:*", "matchCriteriaId": "C5C154F1-7F29-4EC0-9971-76A02C6DA8BC", "versionEndExcluding": "3.0", "vulnerable": true}], "negate": false, "operator": "OR"}, {"cpeMatch": [{"criteria": "cpe:2.3:h:sooil:diabecare_rs:-:*:*:*:*:*:*:*", "matchCriteriaId": "8628A530-AF34-453E-968A-40DD5B8EE456", "vulnerable": false}], "negate": false, "operator": "OR"}], "operator": "AND"}], "cveTags": [], "descriptions": [{"lang": "en", "value": "In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications use deterministic keys, which allows unauthenticated, physically proximate attackers to brute-force the keys via Bluetooth Low Energy."}, {"lang": "es", "value": "En SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i y AnyDana-A, el protocolo de comunicaci\u00f3n de la bomba de insulina y sus aplicaciones m\u00f3viles AnyDana-i y AnyDana-A, utilizan claves deterministas, lo que permite a atacantes no autenticados y f\u00edsicamente pr\u00f3ximos llevar a cabo ataques de fuerza bruta por medio de Bluetooth Low Energy"}], "id": "CVE-2020-27264", "lastModified": "2021-01-22T15:55:57.520", "metrics": {"cvssMetricV2": [{"acInsufInfo": false, "baseSeverity": "LOW", "cvssData": {"accessComplexity": "LOW", "accessVector": "ADJACENT_NETWORK", "authentication": "NONE", "availabilityImpact": "NONE", "baseScore": 3.3, "confidentialityImpact": "PARTIAL", "integrityImpact": "NONE", "vectorString": "AV:A/AC:L/Au:N/C:P/I:N/A:N", "version": "2.0"}, "exploitabilityScore": 6.5, "impactScore": 2.9, "obtainAllPrivilege": false, "obtainOtherPrivilege": false, "obtainUserPrivilege": false, "source": "nvd@nist.gov", "type": "Primary", "userInteractionRequired": false}], "cvssMetricV31": [{"cvssData": {"attackComplexity": "LOW", "attackVector": "ADJACENT_NETWORK", "availabilityImpact": "HIGH", "baseScore": 8.8, "baseSeverity": "HIGH", "confidentialityImpact": "HIGH", "integrityImpact": "HIGH", "privilegesRequired": "NONE", "scope": "UNCHANGED", "userInteraction": "NONE", "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H", "version": "3.1"}, "exploitabilityScore": 2.8, "impactScore": 5.9, "source": "nvd@nist.gov", "type": "Primary"}]}, "published": "2021-01-19T21:15:14.110", "references": [{"source": "ics-cert@hq.dhs.gov", "tags": ["Third Party Advisory", "US Government Resource"], "url": "https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01"}], "sourceIdentifier": "ics-cert@hq.dhs.gov", "vulnStatus": "Analyzed", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-330"}], "source": "nvd@nist.gov", "type": "Primary"}, {"description": [{"lang": "en", "value": "CWE-330"}], "source": "ics-cert@hq.dhs.gov", "type": "Secondary"}]}